chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report from a contactable other hcp (patient). A 33-year-old non-pregnant female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in left arm on 27Dec2020 (Lot Number: EL1284) (at the age of 33-years-old) as dose 1, single and administered in left arm on 17Jan2021 (Lot Number: EL3246) (at the age of 33-years-old) as dose 2, single for covid-19 immunisation. Medical history included sinusitis and hashimoto's thyroiditis. The patient had no relevant past drug history. The patient did not receive any other concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was tested for COVID-19 since the vaccination. The patient developed vertigo on 19Jan2021, multiple episodes increasing in frequency through early Mar2021. The symptoms returned 2-3 months later, less frequent than previously, but mildly intermittent for several weeks. On 29Jul2021, the patient had polymerase chain reaction (PCR) test (nasal swab) and the result was positive. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient was not hospitalized. The patient received evaluation by vertigo specialist as treatment for vertigo. The outcome of vertigo was recovered with sequelae on an unspecified date in 2021 and outcome all the other events was unknown. The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product bnt162b2 to the reported vaccination failure, COVID-19 cannot be ruled out.
improperly stored vaccine administered; This spontaneous report as received from an administrator refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On 22-JAN-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA)(PROQUAD) 0.5 ml, lot # S027460, expiration date: 02-MAR-2021 for prophylaxis (route of administration and anatomical location were not reported).  Administered dose of vaccine underwent the temperature excursion of 6 to 14 degrees Fahrenheit (F) (9.3F) for 15 minutes and 6F to 14F (9.1F) for 15 minutes. Digital data logger was involved. There were no previous excursions reported.
CHIEF COMPLAINT: SWELLING IN ANKLES X24 HOURS. PATIENT EXPERIENCED SWELLING IN MOST JOINTS THE MORNING AFTER RECEIVING HER SECOND COVID-19 VACCINATION; THIS BEGAN AT APPROX. 08:00AM ON 2-25-21 AND LASTED FOR A TOTAL OF 24 HOURS. SWELLING WAS MAINLY LOCALIZED TO ANKLES, WRISTS, FINGERS (IN ORDER OF SEVERITY.) PATIENT EXPERIENCED FEVER AT APPROX.  23:59PM ON 2-25-21 WHICH WAS RESOLVED BY THE FOLLOWING MORNING S/P TREATMENT WITH IBUOROFEN OTC. ALL SX (SWELLING/FEVER RESOLVED BY 08:00AM ON 2-26-21.
ABOUT 12 HOURS AFTER VACCINATION PATIENT EXPERIENCED INJECTION SITE ITCHING, PAIN, REDNESS AND SWELLING ABOUT THE SIZE OF HER PALM. AT THIS TIME THE SYMPTOMS HAVE NOT IMPROVED. PATIENT WAS TOLD SHE COULD USE TYLENOL OR MOTRIN FOR PAIN AND SWELLING AND HYDROCORTISONE FOR ITCH. SHE WAS TOLD TO SEEK MEDICAL ATTENTION IF SYMPTOMS DID NOT IMPROVE INA FEW DAYS. SHE SAID SHE MAY CALL HER MD
About 1 day after the vaccine was received, the patient stated he had a hard time getting out of bed, he was extremely tired and sleepy, and also had trouble walking. All of this was unusual for him and lasted for about a day. He also stated that he almost went to the hospital due to these reactions. He did not have any skin irritation or local reaction. He also stated he has never had a bad reaction to any flu shots in the past.
shingles; Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown gender, who was currently 70 years-old. The patient's past medical history, concurrent conditions, or concomitant medication were not reported.   On 13-SEP-2013, the patient was inoculated with the zoster vaccine live (ZOSTAVAX) (lot number, expiration date, dosage and route of administration were not provided) at a pharmacy, for the long-term prevention of shingles and zoster-related conditions.   On an unknown date, the patient was treated by a physician for shingles. The outcome of the shingles was unknown and the casuality assessment between the singles and the vaccination with zoster vaccine live (ZOSTAVAX) was reported as related.
I started feeling nausea on that Sunday night thought it was related to something I ate. I tolerated a liquid diet due to severe cramps in my stomach. I wasn't unable to go to work I was in so much pain. The Friday after I went to the  doctor possibly thought maybe due to Diabetes. I got blood work done , MRI for abdomen issues to rule out tumor. After a week started to add solid foods back into my diet began to feel better.
Member was only 17 year of age.  Fist dose in series was administered on 20 FEB 2021 and was not identified until 2 dose was given on 22 MAR 2021.  Member reported no adverse events from the first dose and has had not had any adverse events from 2nd dose at this time.
Pt was feeling throat tightness, nasal and full body itching, and dizziness that was worsening.  Received 25mg Benedryl liquid at 1:05 pm and taken to the ED via wheelchair at 1:07pm, due to worsening dizziness and itching.  Pt was hemodynamically stable at the ED, but had relapse of suicidal ideation. She was observed for several hours before being released back to the local jail where she had been in custody before this visit.
Told by male nurse frozen vaccine. Vertigo, tinnitus, field of vision lowered, speech slurred.
Unable to lift arm, as bad as 1st time,injected into left arm and since injection, patient has been unable to lift left arm; difficulty putting on jacket; This case was reported by a consumer via call center representative and described the occurrence of injected limb mobility decreased in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of mobility decreased (received 1st on an unknown date, refer link case US2022AMR178393).   On 23rd September 2022, the patient received the 2nd dose of Shingrix. On 23rd September 2022, less than a day after receiving Shingrix, the patient experienced injected limb mobility decreased and activities of daily living impaired. On an unknown date, the outcome of the injected limb mobility decreased and activities of daily living impaired were not recovered/not resolved.   It was unknown if the reporter considered the injected limb mobility decreased and activities of daily living impaired to be related to Shingrix.     Linked case(s) involving the same patient:  US2022AMR178393   Additional Information: GSK receipt date: 28-NOV-2022 Reporter's comment: The patient reported that after the 2nd dose she was been unable to lift her left arm.  The patient date of birth and lot number, expiry date was not requested.  The 2nd dose was injected into left arm and since injection, patient had been unable to lift left arm, stated she had difficulty putting on jacket.  The patient also stated that the 2nd time was just as bad as the 1st time but was still ongoing.  The reporter consented to follow-up. Additional Supportive Information: This case linked with case US2022AMR178393 reported by same reporter.; Sender's Comments:  US-GSK-US2022AMR178393:Same reporter
No adverse event. Received Bivalent booster as 1st dose. Has not received primary series yet.
I was diagnosed with a pulmonary embolism in each lobe of my right lung on 24May2021; This is a spontaneous report from a contactable consumer (patient). A 33-year-old female patient (not pregnant at the time of vaccination) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EL3247), via an unspecified route of administration in left arm on 25Feb2021 (at the age of 33 years old) as single for covid-19 immunisation. Medical history included brain tumor, chronic migraine, premature ovarian failure. The patient had known allergies to codene, dust, tree pollen. The patient received other concomitant medications in the past two weeks. The patient did not receive any other vaccines within four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient underwent lab tests and procedures which included nasal swab sars-cov-2 test: negative on 24May2021. On 24May2021, patient was diagnosed with a pulmonary embolism in each lobe of right lung. The event resulted in: Emergency room/department or urgent care, hospitalization. The patient was hospitalized for 9 days. The patient received treatment due to the event with placed on heprin, evaluated for additional clots. The reporter considered events as serious. Since the vaccination, the patient tested for COVID-19. The outcome of event was resolving.
On the first day after the second dose, I had several instances of diarrhea. I was not incapacitated. I kept hydration up and it was an expected side effect. Ever since, I have a daily bout of mild diarrhea. I also often need an antacid after meals, and this is not normal. No treatment has been necessary. I am not terribly sick, and usually it is ONE episode/day of diarrhea, but the indigestion varies.  The exact same food doesn't always have the same impact- the same foods (like an identical breakfast) can cause me no trouble one day, and require an antacid the next day.
At 5:50 am, the morning after receiving the vaccine, I had heart pain that occurred for ~1min. The pain woke me up.  After this incident, I've had heart flutters/palpitations and heavy heart beating while at rest for the last 28 days.
Throat and face swelling, wheezing, for several hours, then sore throat and hoarseness with red tearing eyes for several more hours and into the next day. Dr. called but not seen, as I was feeling much better.
Information has been received from a physician concerning a 13 months old male who on 24-JUL-2009 was vaccinated with VARIVAX (Merck, LOT # was not provided). On 06-AUG-2009 (13 days after vaccination) the patient experienced a varicella injection site reaction. The outcome of the patient was not recovered. It was unknown that the patient sought medical attention. Additional information has been requested.
Patient complained of headache after a few minutes of FLUVIRIN vaccine. Called pat later time to follow up, per pat still has HA. Informed pat. to contact MD of headache, per MD service.
10/13/2003 @ 9:30 AM: Started to swell at 14:00.  Swelling from shoulder to elbow.  Hot to touch red, pain.
Vaccinated at 10:15 am observed x 30 min, left called at 11:15 reporting bronchospasm 11:25, Xopenex neb at 11:40, Zyrtec PO, Epi 0.3 SQ at 11:45. Home on Zyrtec and Tagamet PO.
No reaction during 15 min "wait" time at flu shot clinic. Reaction occurred 10-15 min after leaving clinic- she felt "sweaty" and "ill allover". Client called 1 week after shot and said she had a terrible week. Weakness and generally feeling poorly x 1 week. Symptoms resolved 10/21/08
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age. On an unknown date the patients were vaccinated with improperly stored PROQUAD lot # N013270, 0.5 ml, subcutaneous for prophylaxis. Concomitant therapies included sterile diluent. On an unknown date the patient experienced no adverse event.
Severe pain in Spine and lower back into both legs and feet. Pain feels like lightening bolts, sharp shooting quality. Pain so severe I could not lay on back nor could I sit or bend over. Started 48 hours after vaccine #2 and # 3. Pain more severe after vaccine number three so severe it required a trip to the ER. Pain No increasing and still present on September 8 2021.
Strange sensation in neck progressing into a stiff neck, like you slept on the wrong side of your neck; Spacy and light headed and dizzy-ish; light headed and dizzy-ish; listlessness came back slightly, then that was it. Confirmed the spaciness and listlessness went hand in hand.; Everything was sore/but last night his right shoulder did get sore right away eventually; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 25Mar2021 10:00 (Lot number: ER8732) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Migraines" (unspecified if ongoing), notes: Verbatim: migraines; "leaky gut" (unspecified if ongoing), notes: History leaky gut; "Bronchial hyperreactivity" (unspecified if ongoing), notes: Reactive airways disease; "High Iron" (unspecified if ongoing), notes: occasionally high iron; "erratic heart beat" (unspecified if ongoing), notes: Erratic heart beat; "heart palpitations" (unspecified if ongoing), notes: 5 years ago he had sudden onset heart palpitations,. The patient's concomitant medications were not reported. The following information was reported: MUSCULOSKELETAL STIFFNESS (non-serious) with onset 25Mar2021, outcome "recovered" (29Mar2021), described as "Strange sensation in neck progressing into a stiff neck, like you slept on the wrong side of your neck"; FEELING ABNORMAL (non-serious) with onset 25Mar2021, outcome "unknown", described as "Spacy and light headed and dizzy-ish"; DIZZINESS (non-serious) with onset 25Mar2021, outcome "unknown", described as "light headed and dizzy-ish"; LISTLESS (non-serious) with onset 25Mar2021, outcome "unknown", described as "listlessness came back slightly, then that was it. Confirmed the spaciness and listlessness went hand in hand. "; ARTHRALGIA (non-serious) with onset 25Mar2021, outcome "recovered" (29Mar2021), described as "Everything was sore/but last night his right shoulder did get sore right away eventually".  Additional information included Caller does mention that a couple of hours before both doses of the Pfizer COVID-19 vaccine he took  a half of a pill of over the counter generic 12 hour Claritin a couple of hours before each shot before each shot. Caller also adds that him or his wife didn't drink four days after the first dose of Pfizer COVID-19 vaccine  taking supplements have to do with anti-clotting and blood thinning attributes like fish oil and turmeric. Caller states he does take an 81mg aspirin from time to time, and has taken 2 in the last couple of days. Caller states he does not normally take them that often. With no to Emergency Room and Physician Office. Caller states he tested negative for 01Mar2021 antibodies. He wanted to make sure he didnt have antibodies or exposed to covid prior to the shot.   No follow-up attempts are possible. No further information is expected.
Large red raised area around site Warm to touch Itchy at site Painful to touch  No intervention. Lasted for 4-5 days
Itching at her injection site; A 4cm circle of red rash at injection site; A 4cm circle of red rash at injection site; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PRURITUS (Itching at her injection site), VACCINATION SITE RASH (A 4cm circle of red rash at injection site) and VACCINATION SITE ERYTHEMA (A 4cm circle of red rash at injection site) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Sleep disorder NOS.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at her injection site), VACCINATION SITE RASH (A 4cm circle of red rash at injection site) and VACCINATION SITE ERYTHEMA (A 4cm circle of red rash at injection site). At the time of the report, VACCINATION SITE PRURITUS (Itching at her injection site), VACCINATION SITE RASH (A 4cm circle of red rash at injection site) and VACCINATION SITE ERYTHEMA (A 4cm circle of red rash at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-Apr-2021: Follow up received on 24 Apr 2021. No new information were reported.
Severe aches and slight fever started 24 hrs after injection.  Prior positive Covid 5 months prior with symptoms.  Still experiencing parasomia (partial loss of smell).   Symptoms of post injection side effects managed with Tylenol.  Aches/fever lasted about 18 hours.
This spontaneous report was received from a register nurse, refers to an unspecified number of patients, of unknown age and gender. Medical history and concurrent conditions were not reported. The register nurse informed that on an unknown date the patients received improperly stored, GARDASIL (strength, dosage, route, lot# and expiration date were not reported). No adverse were reported. This is one of several reports received from the same reporter. Additional information has been requested.
c/o 1 1/2"-2" induration to the lt of the site of inject & warmness around site; Pt states had been draining bloody pus since this AM; Seen by MD;
Cough  Exposure to COVID-19 virus  Fatigue, unspecified type  Tension headache   Suspected COVID-19 virus infection  Mild intermittent asthma with acute exacerbation  URI, acute
24OCT94 recvd vax 130PM approx 6PM cont crying, shrill crying; mom states child had fever by touching had not thermometer; pt fussy & was unable to sleep; MD called the next day & stated it was a react to pertussis;
@0928 about 20 minutes post vaccine, she stated she was starting to feel tingling to her neck and arms bilaterally. NAD, no SOB, v/s 154/110 (normal for her is 102/80s). 98% RA, hr 95, 96.9 temp and no pain. Did report dizziness. patient has a history of anaphylaxis. Evaluated her for 30 minutes after onset of symptoms. C/o anxiety and feeling seasick, never experienced respiratory distress at the end of her additional 30 minutes she reported feeling better.
2 hours after receiving vaccine arm was swollen & painful. The next morning was worse with swelling from shoulder to elbow. Went to urgent care, admitted to hospital. Dx with blood clot to left arm. Hospitalized 5 days with heparin injections.
3 DAYS AFTER MMR ONSET OF FEVER OF 104 AND DIARRHEA. LASTED 5-6 DAYS
Left eye drooping; Rash and swollen of upper cheek bone; Rash and swollen of upper cheek bones; This is a spontaneous report from a contactable nurse (patient) via other health care professional. A 82-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), via an unspecified route of administration, administered in left arm in Feb2021 at 13:15 as dose 1, single for COVID-19 immunization. Medical history included heart surgery and allergy to statin and antidepressants. Concomitant medications included apixaban (ELIQUIS); acetylsalicylic acid (ASPIRIN 81) and multivitamins. The patient was not pregnant. The patient was not tested for COVID post vaccination and did not have COVID prior vaccination. In Feb021 at 14:15, the patient experienced rash and swollen of upper cheek bones, left eye drooping. No corrective treatment was received by the patient. The outcome was not recovered for the reported events.  No follow-up attempts are possible. Information on lot/batch number cannot be obtained. No further information is expected.
Chest Pain on 14 APR 2021 at 5 PM Chest Pain getting worse on 15 APR 2021 around 6 PM after dinner. Will visit to doctor office tomorrow 16 APR 2021 if appointment available.
significant tinnitus in both ears began shortly after 1st booster and has continued now for over a year
Administered Novartis H1N1 (4 yrs and older) vaccine 0.25 mL IM, right deltoid. Should have given Sanofi Pasteur H1N1 (6 months and older) 0.25 mL IM. No signs or symptoms of distress noted.
Felt fine first shot. Had a very large knot on my arm that hurt and was very hot to the touch. I developed a blister at the injection site. Spot lasted almost a month.   Second shot I was fine until around 12-14 hours I woke up and experienced a fever and horrible bone pain. I?ve never had my bones hurt. It was awful. Even with meds I was still very weak, and in pain for a day and half. Fever broke after about 12 hours.
Patient felt warm and diaphoretic. Skin pale and clammy. Patient stated she felt short of breath but denied any throat tightness or tongue swelling.  Bp noted to be 72/40 and P 52. Patient transferred to cot, cool compress applied, and apple juice given. Emergency services called to assess patient due to low Bp noted. Vitals improved to 110/74 and P 68. Patient started to feel better and did not need to be transferred to hospital. Patient went home in stable condition.